Melatonin
This medicine should always be taken exactly as described in the patient leaflet or as directed by a doctor or pharmacist.
Table of contents of the leaflet:
Melatonin Pharma Nord contains the active substance melatonin. Melatonin Pharma Nord can be used for the short-term treatment of symptoms related to jet lag in adults. Jet lag symptoms include sleep disturbances, daytime fatigue, tiredness, mild mental disorders, irritability, and gastrointestinal disorders.
How Melatonin Pharma Nord works
Melatonin is a hormone produced by the body that synchronizes the body's day/night biological rhythm. Traveling across time zones can disrupt the biological rhythm, causing jet lag symptoms. The symptoms and their severity may vary from person to person, but they are usually more severe and last longer the more time zones crossed. Melatonin Pharma Nord can help restore the normal day/night rhythm and alleviate symptoms.
If there is no improvement after 5 days or the patient feels worse, they should contact their doctor.
(listed in section 6).
Before starting treatment with Melatonin Pharma Nord, the patient should discuss with their doctor or pharmacist:
This medicine should not be given to children and adolescents from 0 to 18 years of age, as the safety and efficacy of the medicine for the short-term treatment of jet lag symptoms have not been established.
The patient should tell their doctor or pharmacist about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before taking this medicine.
Pregnancy
Melatonin Pharma Nord is not recommended for pregnant women. Melatonin passes through the placenta, and there is not enough information about the risk it may pose to the unborn child.
Women of childbearing age must use effective contraception while taking this medicine.
Breastfeeding
Melatonin Pharma Nord is not recommended for breastfeeding women. Melatonin passes into human milk, and the risk to the breastfed child cannot be excluded.
Fertility
Melatonin Pharma Nord is not recommended for women and men planning to have a child, as there is not enough information about the effect of melatonin on female and male fertility.
Melatonin Pharma Nord may cause drowsiness and reduced alertness for several hours after taking. Therefore, the patient should not take this medicine before driving or operating machinery.
The medicine contains less than 1 mmol (23 mg) of sodium per coated tablet, which means the medicine is considered "sodium-free".
This medicine should always be taken exactly as described in the patient leaflet or as directed by a doctor or pharmacist. If in doubt, the patient should consult their doctor or pharmacist.
The recommended dose for adults and the elderly is 1 tablet taken once a day, for a maximum of 5 days. If the effect of Melatonin Pharma Nord is insufficient, 2 tablets can be taken together the next evening. The dose that sufficiently alleviates symptoms should be taken for the shortest possible period.
The first dose should be taken after arriving at the destination at the usual time of going to bed. Subsequent doses should also be taken at the usual time of going to bed. The patient should not take the tablets before 8:00 PM or after 4:00 AM.
The tablets should be swallowed whole and washed down with water or another liquid (such as milk, fruit juice).
It is recommended not to eat for at least 2 hours before and at least 2 hours after taking Melatonin Pharma Nord. If the patient has impaired glucose tolerance or diabetes, it is best not to take Melatonin Pharma Nord for at least 3 hours after a meal.
Melatonin Pharma Nord 3 mg can be taken for a maximum of 16 treatment periods per year.
If the patient has taken a higher dose of Melatonin Pharma Nord than recommended and does not feel well, they should contact their doctor, hospital, or pharmacist.
The most common symptoms of overdose are drowsiness, headache, dizziness, and nausea.
If the patient misses a dose and wakes up during the night, they can take the missed dose, but not later than 4:00 AM.
The patient should not take a double dose to make up for the missed dose.
If the patient stops taking this medicine, it will not have a harmful effect or cause withdrawal symptoms.
If the patient has any further doubts about the use of this medicine, they should consult their doctor or pharmacist.
Like all medicines, Melatonin Pharma Nord can cause side effects, although not everybody gets them.
If the patient experiences any of the following side effects, they should stop taking the medicine and immediatelycontact their doctor:
Uncommon side effects(may affect up to 1 in 100 people treated)
Rare side effects(may affect up to 1 in 1,000 people treated)
Frequency not known(frequency cannot be estimated from the available data)
If the patient experiences any of the following side effects, they should contact their doctor or pharmacist:
Common side effects(may affect up to 1 in 10 people)
Uncommon side effects(may affect up to 1 in 100 people)
Rare side effects(may affect up to 1 in 1,000 people)
Frequency not known(frequency cannot be estimated from the available data)
If the patient experiences any side effects, including any side effects not listed in this leaflet, they should tell their doctor or pharmacist. Side effects can be reported directly to the Department of Post-Marketing Surveillance of Adverse Reactions to Medicinal Products, Medical Devices, and Biocides of the Office for Registration of Medicinal Products, Medical Devices, and Biocides.
Al. Jerozolimskie 181C
PL-02 222 Warsaw
Tel.: + 48 22 49 21 301
Fax: + 48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help to gather more information on the safety of the medicine.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines they no longer use. This will help protect the environment.
Round, biconvex, coated, white or almost white tablet. Size: 7.5 mm.
Packaging: blister pack containing 10 or 30 coated tablets in a cardboard box.
Not all pack sizes may be marketed.
Pharma Nord ApS
Tinglykke 4-6
6500 Vojens
Denmark
To obtain more detailed information about this medicine, the patient should contact the local representative of the marketing authorization holder:
Pharma Nord sp. z o.o.
ul. Zwoleńska 24C
04-761 Warsaw
tel.: 022 615 27 22
email: info@pharmanord.pl
Belgium
Melatonine Pharma Nord 3 mg film-coated tablets / filmomhulde tabletten / Filmtabletten
E | stonia | Melatoniin Pharma Nord 3 mg õhukese polümeerikattega tabletid |
Hungary | Melatonin Pharma Nord 3 mg filmtabletta | |
I | reland | Melatonin Pharma Nord 3 mg film-coated tablets |
L | atvia | Melatonins Pharma Nord 3 mg apvalkotās tabletes |
L | ithuania | Melatoninas Pharma Nord 3 mg plėvele dengtos tabletės |
N | etherlands | Melatonine Pharma Nord 3 mg filmomhulde tablet |
P | oland | Melatonina Pharma Nord 3 mg tabletki powlekane |
P | ortugal | Melatonina Pharma Nord 3 mg, comprimidos revestidos por película |
S | pain | Melatonina Pharma Nord 3 mg comprimidos recubiertos con película |
(U | nited Kingdom Northern Ireland) | Syncrodin 3 mg film-coated tablets |
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.